Insider Transactions in Q2 2021 at Tandem Diabetes Care Inc (TNDM)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 28
2021
|
James Leal Chief Manufacturing Officer |
SELL
Open market or private sale
|
Direct |
7,135
-66.49%
|
$713,500
$100.0 P/Share
|
|
Jun 28
2021
|
James Leal Chief Manufacturing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,135
+21.78%
|
$214,050
$30.25 P/Share
|
|
Jun 23
2021
|
Douglas A Roeder Director |
BUY
Other acquisition or disposition
|
Indirect |
1,892
+0.19%
|
-
|
|
Jun 23
2021
|
Douglas A Roeder Director |
SELL
Other acquisition or disposition
|
Direct |
1,892
-100.0%
|
-
|
|
Jun 11
2021
|
Kim D Blickenstaff Director |
SELL
Bona fide gift
|
Indirect |
12,000
-0.97%
|
$1,092,000
$91.51 P/Share
|
|
Jun 10
2021
|
Dick Allen Director |
BUY
Other acquisition or disposition
|
Indirect |
1,892
+6.57%
|
-
|
|
Jun 10
2021
|
Dick Allen Director |
SELL
Other acquisition or disposition
|
Direct |
1,892
-100.0%
|
-
|
|
Jun 09
2021
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
500
-20.9%
|
$45,000
$90.0 P/Share
|
|
Jun 09
2021
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+17.29%
|
$17,000
$34.0 P/Share
|
|
Jun 08
2021
|
Kathleen Mc Groddy Goetz Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,219
+50.0%
|
-
|
|
Jun 08
2021
|
Kim D Blickenstaff Director |
SELL
Open market or private sale
|
Indirect |
38,000
-2.87%
|
$3,344,000
$88.44 P/Share
|
|
Jun 01
2021
|
Rebecca B Robertson Director |
SELL
Open market or private sale
|
Direct |
1,000
-34.58%
|
$85,000
$85.11 P/Share
|
|
Jun 01
2021
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+25.69%
|
$34,000
$34.0 P/Share
|
|
May 28
2021
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,619
-27.3%
|
$311,234
$86.47 P/Share
|
|
May 28
2021
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,854
+19.49%
|
$16,686
$9.0 P/Share
|
|
May 27
2021
|
John F Sheridan PRESIDENT & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,134
-15.47%
|
$96,390
$85.65 P/Share
|
|
May 27
2021
|
John F Sheridan PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,279
+30.9%
|
-
|
|
May 27
2021
|
Susan Morrison EVP & Chief Admin. Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
466
-5.7%
|
$39,610
$85.65 P/Share
|
|
May 27
2021
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,626
+16.59%
|
-
|
|
May 27
2021
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
563
-8.74%
|
$47,855
$85.65 P/Share
|
|
May 27
2021
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,626
+20.15%
|
-
|
|
May 27
2021
|
Dick Allen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+50.0%
|
-
|
|
May 27
2021
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
528
-8.02%
|
$44,880
$85.65 P/Share
|
|
May 27
2021
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,626
+19.8%
|
-
|
|
May 27
2021
|
Rebecca B Robertson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+50.0%
|
-
|
|
May 27
2021
|
Kim D Blickenstaff Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+50.0%
|
-
|
|
May 27
2021
|
Christopher J Twomey Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+50.0%
|
-
|
|
May 27
2021
|
David B Berger EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
681
-10.5%
|
$57,885
$85.65 P/Share
|
|
May 27
2021
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,626
+20.04%
|
-
|
|
May 27
2021
|
Douglas A Roeder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,892
+50.0%
|
-
|
|
May 19
2021
|
Christopher J Twomey Director |
SELL
Open market or private sale
|
Indirect |
269
-0.77%
|
$23,941
$89.03 P/Share
|
|
May 19
2021
|
Christopher J Twomey Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
324
+0.92%
|
$23,652
$73.73 P/Share
|
|
May 18
2021
|
David B Berger EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Indirect |
201
-45.37%
|
$17,889
$89.14 P/Share
|
|
May 18
2021
|
David B Berger EVP & Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Indirect |
243
+35.42%
|
$17,739
$73.73 P/Share
|
|
May 17
2021
|
Leigh Vosseller EVP & CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
296
+5.79%
|
$19,536
$66.76 P/Share
|
|
May 17
2021
|
Susan Morrison EVP & Chief Admin. Officer |
BUY
Grant, award, or other acquisition
|
Direct |
296
+4.32%
|
$19,536
$66.76 P/Share
|
|
May 17
2021
|
Brian B Hansen EVP & CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
296
+5.63%
|
$19,536
$66.76 P/Share
|
|
May 17
2021
|
David B Berger EVP & Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
296
+5.74%
|
$19,536
$66.76 P/Share
|
|
May 17
2021
|
John F Sheridan PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
296
+6.81%
|
$19,536
$66.76 P/Share
|
|
Apr 22
2021
|
Christopher J Twomey Director |
SELL
Open market or private sale
|
Indirect |
4,802
-10.97%
|
$456,190
$95.0 P/Share
|
|
Apr 22
2021
|
Christopher J Twomey Director |
SELL
Bona fide gift
|
Indirect |
2,500
-11.11%
|
$232,500
$93.64 P/Share
|
|
Apr 21
2021
|
Christopher J Twomey Director |
SELL
Open market or private sale
|
Indirect |
3,198
-7.48%
|
$303,810
$95.02 P/Share
|